Eurythmy Therapy for Hiccups

Erdmuthe Worel, Eurythmy Therapy Team Klinik Arlesheim, Andreas Worel

Last update: 14.08.2019

When treating pathological hiccups, the aim is to help the patient’s ‘I’-organization and soul body to get a “firm footing” again, as well as expand the patient’s experience of time and space away from being trapped in the constricting gesture of involuntary diaphragmatic contractions.

Therapeutic recommendations

  • The “Floor O” exercise
    This is an exercise performed by two people together, helping to overcome the inhibitions associated with moving one’s body. The original instructions can be found in the book “Eurythmy therapy” by Rudolf Steiner (1, p. 72, or p. 63 English edition). The exercise includes an element of acceleration and deceleration.

  • For bedridden patients: “I” and “S”
    If the “Floor O” exercise is not possible because the patient is bedridden, sounds such as “I” and a ‘commanding’ “S” in the periphery, possibly done only with individual fingers or toes, are very helpful.

  • “M” and “L”
    In addition, “M” with the feet in a countermovement can be brought together with a quiet “L” from the periphery.

  • For exhaustion due to hiccups: “L – M – S – U”
    If the hiccups have already led to exhaustion, the feet can be moved passively in “L – M – S – U” . If the patient can only sit, the “S” can also be drawn with the feet on the floor.

  • With the exercise “Sympathy – Antipathy”
    the ‘I’-organization can succeed in recovering control of the soul body and release the cramp in the thorax and diaphragm.

Bibliography

  1. Steiner R. Heileurythmie. GA 315. Lecture of April 16, 1921. 5th ed. Dornach: Rudolf Steiner Verlag; 2003. English translation: Steiner R. Eurythmy therapy. London: Rudolf Steiner Press; 2009.

Research news

Case series: Topical application of Viscum album extract in keratinocyte carcinomas shows remissions 
A retrospective case series examined the safety and clinical effects of topical application of 10% lipophilic Viscum album extract (VALE) in individual cases of cutaneous squamous cell carcinoma (cSCC), basal cell carcinoma (BCC) and actinic keratosis (AK). The study population consisted of 55 patients with 74 skin lesions. Risk factors, concomitant therapies and diseases, adverse drug reactions to VALE and other relevant information were documented. As a result, the clinical response rate was 78% for cSCC, 70% for BCC and 71% for AK. The complete remission rates for individual lesions were 56% for cSCC, 35% for BCC and 15% for AK. Overall, the results suggest that VALE is a safe and tolerable extract, and complete and partial remissions of ceratinocyte carcinomas were observed with its use. The article is published in Complementary Medicine Research
https://doi.org/10.1159/000537979.


Further information on Anthroposophic Medicine